Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo







Vol. 54, No. 4, 2008 
Free Access

View or print article as PDF (195 KB)   
 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 18667815)
Medline Related Articles
Download Citation

Review

Optimization of Antibiotic Use in Hospitals - Antimicrobial Stewardship and the EU Project ABS International
Franz Allerberger, Arno Lechner, Agnes Wechsler-Fördös, Roland Gareis, on behalf of ABS International

ABS-Group, Project Office, Roland Gareis Consulting, Vienna, Austria

Address of Corresponding Author

Chemotherapy 2008;54:260-267 (DOI: 10.1159/000149716)


 goto top of outline Key Words

  • Antibiotics
  • Antimicrobials
  • Resistance
  • Stewardship
  • Project

 goto top of outline Abstract

Background: The problem of antimicrobial resistance requires common strategies at the European level. Methods: We report on an EU initiative fostering antibiotic (AB) stewardship (ABS) in hospitals. Results: The project 'ABS International: implementing antibiotic strategies for appropriate use of antibiotics in hospitals in member states of the EU' started in September 2006 in Austria, Belgium, the Czech Republic, Germany, Hungary, Italy, Poland, Slovenia and Slovakia. A training program for national ABS trainers was prepared and standard templates for ABS tools (AB list, guidelines for AB treatment and surgical prophylaxis, and AB-related organization) and valid process measures as well as quality indicators for AB use were developed. Specific ABS tools are being implemented in up to five health care facilities per country. Conclusion: ABS International is the first EU-funded initiative focusing on the implementation of structural measures in hospitals to promote the prudent use of ABs.

Copyright © 2008 S. Karger AG, Basel


 goto top of outline References


1.
McLoughlin A, O'Morain C: Effectiveness of antiinfectives. Chemotherapy 2005;51:243-246. External Resources

2.
Raveh D, Yinnon AM, Broide E, Rudensky B: Susceptibilities of ESCL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid. Chemotherapy 2007;53:185-189. External Resources

3.
Tenover FC, Hughes JM: The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA 1996;275:300-304. External Resources

4.
Wise R: Antimicrobial resistance: paradox, actions and economics. J Antimicrob Chemother 2006;57:1189-1196. External Resources

5.
Anonymous: Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). OJEU 2002;45:13-16.

6.
Gould IM: Stewardship of antibiotic use and resistance surveillance: the international scene. J Hosp Infect 1999;43:S253-S260. External Resources

7.
MacDougall C, Polk ER: Antimicrobial Stewardship Programs in Health Care Systems. Clin Microbiol Rev 2005;18:638-656. External Resources

8.
Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159-177. External Resources

9.
Allerberger F, Gareis R, Janata O, Koller W, Lechner A, Mittermayer H, Pecnik I, Reisinger E, Rotter-leBeau M, Wechsler-Fördös A, Zuchi D: ABS Projekt Leitlinien zur Weiterentwicklung der Antibiotika-Kultur in Krankenanstalten. Vienna, Bundesministerium für Arbeit, Gesundheit und Soziales, 1998.

10.
Allerberger F, Gareis R, Janata O, Koller W, Lechner A, Mittermayer H, Pecnik L, Reisinger E, Rotter-leBeau M, Wechsler-Fördös A, Zuchi D: The ABS Project: guidelines to further develop and define antibiotic use in hospitals. Vienna, Federal Ministry for Social Security and Generations, 2000, www.antibiotika-strategien.at.

11.
Allerberger F, Gareis R, Janata O, Krause R, Meusburger S, Mittermayer H, Rotter-leBeau M, Watschinger R, Wechsler-Fördös A: ABS Projekt Leitlinien zur Weiterentwicklung der Antibiotika-Kultur in Krankenanstalten. ed 2, revised. Vienna, Bundesministerium für soziale Sicherheit und Generationen, 2002.

12.
Woodward RS, Medoff G, Smith MD, Gray JL: Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 1987;83:817-823. External Resources

13.
Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD: Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991;90:439-444. External Resources

14.
Maswoswe JJ, Okpara AU: Enforcing a policy for restricting antimicrobial drug use. Am J Health Syst Pharm 1995;52:1433-1435. External Resources

15.
White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB: Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25:230-239. External Resources

16.
MacKenzie FM, Monnet DL, Gould IM, ARPAC Steering Group: Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 2006;58:657-660. External Resources

17.
May AK, Melton SM, McGwin G, Cross JM, Moser SA, Rue LW: Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock 2000;14:259-264. External Resources

18.
Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs). Oslo, WHO Collaborating Center for Drug Statistics Methodology, 2005, http://www.whocc.no/atcddd/ or http://www.escmid.org/sites/index_f.aspx?par=2.5

19.
White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB: Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25:230-239. External Resources

20.
Gould IM: Minimum antibiotic stewardship measures. Clin Microbiol Infect 2001;7 (suppl 6):22-26. External Resources

21.
Holmes WF: Conflicts of interest between the prescriber, the regulator and the profit maker. Clin Microbiol Infect 2001;7(suppl 6):9-11. External Resources

22.
Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG: A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000;283:749-755. External Resources

23.
Price J, Ekleberry A, Grover A, Melendy S, Baddam K, McMahon J, Villalba M, Johnson M, Zervos MJ: Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit Care Med 1999;27:2118-2124. External Resources

24.
Scottish Intercollegiate Guideline Network: Antibiotic Prophylaxis in Surgery. A National Clinical Guideline. Edinburgh, SIGN, 2000, SIGN Pub No 45.

25.
Madaras-Kelly K: Optimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists. Pharmacotherapy 2003;23:1627-1673. External Resources

26.
Interagency Task Force on Antimicrobial Resistance: A public health action plan to combat antimicrobial resistance. I. Domestic issues. Atlanta, Centers for Disease Control and Prevention, 2001, pp 1-43, http://www.cdc.gov/drugresistance/actionplan/index.htm.

27.
Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C: Society for Health Care Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-599. External Resources

28.
Monnet DL: ABC Calc - Antibiotic consumption calculator [Microsoft® Excel application], version 3.0. Copenhagen, Statens Serum Institute, 2005, http://www.ssi.dk/sw379.asp.

29.
Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO: Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001;33:289-295. External Resources

30.
Struelens MJ: Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals. Curr Opin Infect Dis 2003;16:305-307. External Resources

31.
Rybak MJ: Antimicrobial stewardship. Pharmacotherapy 2007;27:131S-135S. External Resources

32.
Metlay JP, Shea JA, Crossette LB, Asch DA: Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 2002;17:87-94. External Resources

33.
Bronzwaer S, Lönnroth A, Haigh R: The European Community strategy against antimicrobial resistance. Euro Surveill 2004;9:30-34. External Resources


 goto top of outline Author Contacts

Univ. Prof. Dr. Franz Allerberger
Österreichische Agentur für Gesundheit und Ernährungssicherheit
Spargelfeldstrasse 191, AT-1220 Wien (Austria)
Tel. +43 50555 35500, Fax +43 50555 25802
E-Mail Franz.Allerberger@ages.at


 goto top of outline Article Information

The Members of ABS International are shown in the Appendix.

Received: May 4, 2007
Accepted after revision: November 26, 2007
Published online: July 31, 2008
Number of Print Pages : 8
Number of Figures : 1, Number of Tables : 1, Number of References : 33


 goto top of outline Publication Details

Chemotherapy (International Journal of Experimental and Clinical Chemotherapy)

Vol. 54, No. 4, Year 2008 (Cover Date: August 2008)

Journal Editor: Sörgel F. (Nürnberg-Heroldsberg)
ISSN: 0009-3157 (Print), eISSN: 1421-9794 (Online)

For additional information: http://www.karger.com/CHE


 goto top of outline Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.

   


copyright  © 2010 S. Karger AG, Basel
  Last update: 26/8/2008